Heimdall Insights

Global Hepatitis B Vaccines Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Hepatitis B Vaccines Market was valued at $8.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.1% CAGR, to an estimated market size of $11.1 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global hepatitis B vaccine market includes biological preparations designed to prevent infection by the Hepatitis B virus (HBV) and its associated complications like cirrhosis and liver cancer. The scope encompasses both monovalent (single-antigen) and multivalent (combination) vaccines, such as hexavalent formulations, administered through pediatric and adult immunization programs. It excludes therapeutic antiviral drugs and interferon therapies.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Hepatitis B Vaccines Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Combination Vaccines
  • Single Antigen Vaccines